Review on Nanotechnology persecute vital role of Curative Applications in Medicinal Field and its ailing Effects
DOI:
https://doi.org/10.46243/jst.2021.v6.i2.pp01-08Keywords:
Cancer therapy, nanobiotechnology, and gene therapy, Nanomedicine, Toxicity of nanoparticlesAbstract
Nowadays, nanotechnology impacts human life every day, and the potential benefits are many and various. In contrast, due to extensive human exposure to nanoparticles, there is an important concern about the potential health and environmental risks. These concerns led to the emergence of further scientific disciplines such as nanotoxicology and nanomedicine. Nanotoxicology which is interesting in the study of potential adverse health effects of nanoparticles.While, Nanomedicine, which includes subsectors such as tissue biomaterials, engineering, biosensors, and bioimaging, was developed to study the benefits and hazards of nanomaterials that are used in medicine and medical devices. In addition, a key promise of nanotechnology is for improved healthcare, including potentiallyrevolutionary treatments for cancer diseases (detection of cancer cells at the early stage) and improved drug delivery (such as reducing side effects), reduced inflammation, antibacterial coverings of medical devices, better surgical tissue therapeutic. However, as result to lack of reliable toxicity data, the potential to affect human health still to be a major concern. The purpose of this literature review is to contribute to a better understanding of the principles and processes the science concepts on which nanobiotechnology meansandits applications in biomedicine will be discussed as well as to their side effects.
References
Jennings, C. H. (2009). Nanotechnology in the USA: Developments, Policies and Issues. Nova Science Publishers, Incorporated
Trgovcević, Z. (1994). 50 years of molecular biology.Lijecnickivjesnik,116(11-12), 315-318
Lewin R. (1987). National Academy looks at human genome.Science,Feb13;235(4790). 747-8
Johnson, R. S. (1987). The human genome project: what impact on basic research?.The FASEB Journal,1(6), 502-505
Yang, Z. R., & Hamer, R. (2007). Bio-basis function neural networks in protein data mining.Current pharmaceutical design, 13(14), 1403-1413
Ahrens, C. H., Wagner, U., Rehrauer, H. K., Türker, C., &Schlapbach, R. (2007). Current challenges and approaches for the synergistic use of systems biology data in the scientific community. InPlant Systems Biology. Birkhäuser Basel, 277-307
ordan, B. R. (1999). ‘Genomics’: Buzzword or reality?Journal of biomedical science,6(3), 145-150
Weyant, R. G. (1967). Lycurgus: The father of applied psychology?American Psychologist,22(6), 432
Tolochko, N. K. (2009). History of nanotechnology.Encyclopedia of Life Support Systems (EOLSS)
Logothetidis, S. (Ed.). (2012).Nanomedicine and nanobiotechnology. Springer Science & Business Media
Bawa, R., Audette, G. F., & Rubinstein, I. (2016).Handbook of clinical nanomedicine: nanoparticles, imaging, therapy, and clinical applications. Pan Stanford
Hulla, J. E., Sahu, S. C., & Hayes, A. W. (2015). Nanotechnology: History and future.Human & experimental toxicology,34(12), 1318- 1321
Jain, K. K. (2004). Applications of biochips: from diagnostics to personalized medicine.Current opinion in drug discovery & development,7(3), 285-289
Brown, E. M. B. (2014). Nanomedicine Advancements in Cancer Diagnosis and Treatment.Horizons in Clinical Nanomedicine, 67
Emerich DF. (2005).Nanomedicine-prospective therapeutic and diagnostic applied usages. Expert Opin. Biol. Ther, Jan;5(1). 1-5
Avti, P. K., Patel, S. C., & Sitharaman, B. (2011). Nanobiomaterials: current status and future prospects.Nanobiomaterials handbook Edited by Balaji Sitharaman. CRC publication
Lee, L. A., & Wang, Q. (2006). Adaptations of nanoscale viruses and other protein cages for medical applications.Nanomedicine: Nanotechnology, Biology and Medicine,2(3), 137-149
Murthy, S. K. (2007). Nanoparticles in modern medicine: state of the art and future challenges.International journal of nanomedicine,2(2), 129-41
Pauwels, E. K., &Erba, P. (2007). Towards the use of nanoparticles in cancer therapy and imaging.Drug news & perspectives,20(4), 213- 220
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005). Nanomedicine: current status and future prospects.The FASEB journal,19(3), 311-330
Gulati, N., & Gupta, H. (2012). Nanomedicine: Potential devices for diagnostics.Recent Patents on Nanomedicine,2(2), 146-155. 6 | Page Review on Nanotechnology persecute vital role of Curative Applications in Medicinal Field and its ailing Effects
Nakayama, M., & Okano, T. (2005). Drug delivery systems using nano-sized drug carriers.Gan to kagakuryoho. Cancer & chemotherapy, 32(7), 935-940
Dutta, R. C. (2007). Drug carriers in pharmaceutical design: promises and progress.Current pharmaceutical design,13(7), 761-769
Dobson, J. (2006). Magnetic micro-and nano-particle-based targeting for drug and gene delivery.Nanomedicine
Freitas, R. A. (2005). Nanotechnology, nanomedicine and nanosurgery.International Journal of Surgery,4(3), 243-246
Ebbesen, M., & Jensen, T. G. (2006). Nanomedicine: techniques, potentials, and ethical implications.BioMed Research International,2006
Fankhauser, F., Niederer, P. F., Kwasniewska, S., & van der Zypen, E. (2004). Supernormal vision, high-resolution retinal imaging, multiphoton imaging and nanosurgery of the cornea–a review.Technology and Health Care,12(6), 443-453
Lamounier, J. A., Moulin, Z. S., & Xavier, C. C. (2004). Recommendations for breastfeeding during maternal infections.Jornal de pediatria, 80(5), s181-s188
Iwaki, Y., Aiba, N., Tran, H. T. T., Ding, X., Hayashi, S., Arakawa, Y., & Abe, K. (2003). Simian TT virus (s-TTV) infection in patients with liver diseases.Hepatology research,25(2), 135-142
Pawłowska, M., &Halota, W. (2004). HCV infections in view of clinical practice.Medical Science Monitor,10(1), 24-28
Filteau, S. M. (2000). Role of breast-feeding in managing malnutrition and infectious disease. Proceedings of the Nutrition Society, 59(4), 565-572
Lawrence, R. M., & Lawrence, R. A. (2004). Breast milk and infection. Clinics in perinatology, 31(3), 501-528
Rajabi, M., Signorelli, P., Gorincioi, E., Ghidoni, R., &Santaniello, E. (2010). Antiproliferative activity of N 6-isopentenyladenosine on MCF-7 breast cancer cells: cell cycle analysis and DNA-binding study.DNA and cell biology,29(11), 687-691
Sahoo, S. K., &Labhasetwar, V. (2003). Nanotech approaches to drug delivery and imaging.Drug discovery today,8(24), 1112-1120
Smith, D. J. (2007).Characterization of nanomaterials using transmission electron microscopy. The Royal Society of Chemistry: Cambridge.1-27
Angeli, E., Buzio, R., Firpo, G., Magrassi, R., Mussi, V., Repetto, L., &Valbusa, U. (2008). Nanotechnology applications in medicine.Tumori Journal, 94(2), 206-215
Rajabi, M., Srinivasan, M., & Mousa, S. A. (2016). Nanobiomaterials in drug delivery. In Nanobiomaterials in Drug Delivery. William Andrew Publishing. 1-37
Allen, T. M., & Martin, F. J. (2004, December). Advantages of liposomal delivery systems for anthracyclines. InSeminars in oncology. WB Saunders. (31), 5-15
Freitas Jr, R. A. (2000). Nanodentistry. The Journal of the American Dental Association, 131(11), 1559-1565
Yao, J., Yang, M., &Duan, Y. (2014). Chemistry, biology, and medicine of fluorescent nanomaterials and related systems: new insights into biosensing, bioimaging, genomics, diagnostics, and therapy.Chemical reviews, 114(12), 6130-6178
Shan, J., &Tenhu, H. (2007). Recent advances in polymer protected gold nanoparticles: synthesis, properties and applications.Chemical Communications, (44), 4580-4598
Cai, W., Gao, T., Hong, H., & Sun, J. (2008). Applications of gold nanoparticles in cancer nanotechnology.Nanotechnology, science and applications, 1, 17
De Jong, W. H., &Borm, P. J. (2008). Drug delivery and nanoparticles: applications and hazards.International journal of nanomedicine,3(2), 133
Sapsford, K. E., Algar, W. R., Berti, L., Gemmill, K. B., Casey, B. J., Oh, E., &Medintz, I. L. (2013). Functionalizing nanoparticles with biological molecules: developing chemistries that facilitate nanotechnology.Chemical reviews,113(3), 1904-2074
Gao, J., Huang, X., Liu, H., Zan, F., & Ren, J. (2012). Colloidal stability of gold nanoparticles modified with thiol compounds: bioconjugation and application in cancer cell imaging.Langmuir, 28(9), 4464-4471
Alexis, F., Rhee, J. W., Richie, J. P., Radovic-Moreno, A. F., Langer, R., &Farokhzad, O. C. (2008, January). New frontiers in nanotechnology for cancer treatment. InUrologic Oncology: Seminars and Original Investigations. Elsevier. 26(1), 74-85
Loos, M. (2014). Carbon nanotube reinforced composites: CNT Polymer Science and Technology. Elsevier
Ju-Nam, Y and Lead, J.(2016). Properties, Sources, Pathways, and Fate of Nanoparticles in the Environment.Engineered Nanoparticles and the Environment: Biophysicochemical Processes and Toxicity. 39-117
Patra, C. R., Bhattacharya, R., Mukhopadhyay, D., & Mukherjee, P. (2010). Fabrication of gold nanoparticles for targeted therapy in pancreatic cancer.Advanced drug delivery reviews, 62(3), 346-361
Zhao, Y., Gu, X., Ma, H., He, X., Liu, M., & Ding, Y. (2011). Association of glutathione level and cytotoxicity of gold nanoparticles in lung cancer cells. The Journal of Physical Chemistry C, 115(26), 12797-12802
Medley, C. D., Smith, J. E., Tang, Z., Wu, Y., Bamrungsap, S., & Tan, W. (2008). Gold nanoparticle-based colorimetric assay for the direct detection of cancerous cells. Analytical chemistry, 80(4), 1067-1072
Cheng, Y., Samia, A. C., Meyers, J. D., Panagopoulos, I., Fei, B., &Burda, C. (2008). Highly efficient drug delivery with gold nanoparticle vectors for in vivo photodynamic therapy of cancer.Journal of the American Chemical Society,130(32), 10643-10647
Piller, C. (2006). Science’s tiny, big unknown. Los Angeles Times, 1, A1
Morgan, K. (2005). Development of a preliminary framework for informing the risk analysis and risk management of nanoparticles.Risk Analysis: An International Journal, 25(6), 1621-1635
Borm, P., Klaessig, F. C., Landry, T. D., Moudgil, B., Pauluhn, J., Thomas, K.,& Wood, S. (2006). Research strategies for safety evaluation of nanomaterials, part V: role of dissolution in biological fate and effects of nanoscale particles. Toxicological Sciences, 90(1), 23-32
Balshaw, D. M., Philbert, M., & Suk, W. A. (2005). Research strategies for safety evaluation of nanomaterials, Part III: nanoscale technologies for assessing risk and improving public health.Toxicological Sciences, 88(2), 298-306
Thomas, T., Thomas, K., Sadrieh, N., Savage, N., Adair, P., &Bronaugh, R. (2006). Research strategies for safety evaluation of nanomaterials, part VII: evaluating consumer exposure to nanoscale materials.Toxicological Sciences, 91(1), 14-19
Love, S. A., Maurer-Jones, M. A., Thompson, J. W., Lin, Y. S., & Haynes, C. L. (2012). Assessing nanoparticle toxicity.Annual review of analytical chemistry,5, 181-205
Lee, S. Y., & Cheng, J. X. (2010). Clearance of nanoparticles during circulation.Pharmaceutical Sciences Encyclopedia: Drug Discovery, Development, and Manufacturing, 1-32
Johnston, H. J., Semmler-Behnke, M., Brown, D. M., Kreyling, W., Tran, L., & Stone, V. (2010). Evaluating the uptake and intracellular fate of polystyrene nanoparticles by primary and hepatocyte cell lines in vitro.Toxicology and applied pharmacology, 242(1), 66-78
Published
How to Cite
Issue
Section
